Postmenopausal osteoporosis: prevention and treatment with calcitonin.
Prelevic
G M
GM
Department of Medicine, University Medical Center Zvezdara, Belgrade, Yugoslavia.
Adashi
E Y
EY
D000906:Antibodies / Q000097:blood; D002116:Calcitonin / Q000009:adverse effects / Q000276:immunology / Q000502:physiology / Q000627:therapeutic use*; D004351:Drug Resistance; D004967:Estrogens / Q000172:deficiency / Q000502:physiology; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D010146:Pain / Q000188:drug therapy
D000906:Antibodies; D004967:Estrogens; D002116:Calcitonin